Osmanodja, Filiz http://orcid.org/0000-0001-6852-057X
Scheitz, Jan F.
Fiebach, Jochen B.
Ganeshan, Ramanan
Villringer, Kersten
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 20 July 2021
Revised: 24 October 2021
Accepted: 25 October 2021
First Online: 9 November 2021
Declarations
:
: Jochen B Fiebach reports personal fees from Abbvie, AC Immune, Artemida, Bioclinica, Biogen, BMS, Brainomix, Cerevast, Daiichi-Sankyo, Eisai, F.Hoffmann-La Roche AG, Eli Lilly, Guerbet, Ionis Pharmaceuticals, IQVIA, Janssen, Julius clinical, Jung diagnostics, Lysogene, Merck, Nicolab, Premier Research, Siemens, and Tau Rx, outside the submitted work.
: In accordance with the Berlin State legislation, no separate ethics committee approval was required for this retrospective analysis.